INS and metabolic syndrome: Pro-inflammatory cytokines decrease insulin secretion in a clonal pancreatic β-cell line, explaining the classical features of metabolic syndrome, including central adiposity, hyperglycemia, and dyslipidemia seen in-vivo models [18].